Pharmacogenetics of Drug-Resistant Epilepsy (Review of Literature)
Open Access
- 28 October 2021
- journal article
- review article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 22 (21) , 11696
Abstract
Pharmacogenomic studies in epilepsy are justified by the high prevalence rate of this disease and the high cost of its treatment, frequent drug resistance, different response to the drug, the possibility of using reliable methods to assess the control of seizures and side effects of antiepileptic drugs. Candidate genes encode proteins involved in pharmacokinetic processes (drug transporters, metabolizing enzymes), pharmacodynamic processes (receptors, ion channels, enzymes, regulatory proteins, secondary messengers) and drug hypersensitivity (immune factors). This article provides an overview of the literature on the influence of genetic factors on treatment in epilepsy.Keywords
This publication has 143 references indexed in Scilit:
- CYP3A5*3 and C3435T MDR1 Polymorphisms in Prognostication of Drug-Resistant Epilepsy in Children and AdolescentsBioMed Research International, 2013
- A Tumor Suppressor Complex with GAP Activity for the Rag GTPases That Signal Amino Acid Sufficiency to mTORC1Science, 2013
- Functional Characterization of a CRH Missense Mutation Identified in an ADNFLE FamilyPLOS ONE, 2013
- Potential role of multidrug resistant proteins in refractory epilepsy and antiepileptic drugs interactionsDrug Metabolism and Drug Interactions, 2011
- Modulation of P-Glycoprotein at the Blood-Brain Barrier: Opportunities to Improve Central Nervous System PharmacotherapyPharmacological Reviews, 2008
- Lack of Support for a Role for RLIP76 (RALBP1) in Response to Treatment or Predisposition to EpilepsyEpilepsia, 2007
- Searching for polymorphisms that affect gene expression and mRNA processing: Example ABCB1 (MDR1)The AAPS Journal, 2006
- Increased Sensitivity of the Neuronal Nicotinic Receptor α2 Subunit Causes Familial Epilepsy with Nocturnal Wandering and Ictal FearThe American Journal of Human Genetics, 2006
- The CHRNB2 mutation I312M is associated with epilepsy and distinct memory deficitsNeurobiology of Disease, 2005
- A de novo mutation in sporadic nocturnal frontal lobe epilepsyAnnals of Neurology, 2000